You are here:

paliperidone (INVEGA)

Advice

in the absence of a submission from the holder of the marketing authorisation

paliperidone (Invega®) is not recommended for use within NHS Scotland.

Indication under review: For the treatment of psychotic or manic symptoms of schizoaffective disorder. Effect on depressive symptoms has not been demonstrated.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: paliperidone (INVEGA)
SMC Drug ID: 702/11
Manufacturer: Janssen-Cilag Ltd
Indication: For the treatment of psychotic or manic symptoms of schizoaffective disorder. Effect on depressive symptoms has not been demonstrated.
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 11 April 2011

Back